Drug intelligence / Profile preview

polysaccharide k

Development stage
Phase 3
Modality
Microbiome-Derived Products → Microbiome Therapeutics, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Polysaccharide K (PSK), also known as Krestin, is a protein-bound beta-glucan polysaccharide extracted from the mycelium of the mushroom *Trametes versicolor* (also known as *Coriolus versicolor* or "turkey tail"). It has been widely used in Japan and other parts of Asia for over 30 years as an adjuvant immunotherapeutic agent in cancer treatment. PSK is approved as a pharmaceutical-grade medicine in Japan and has been used primarily to manage gastric, colon, and colorectal cancers alongside chemotherapy. Its mechanism of action involves immunomodulation—stimulating T cell proliferation; inducing secretion of cytokines such as IL-8 and TNF-alpha by monocytes; enhancing natural killer (NK) cell activity; improving CD4+ T cell function; preventing cyclophosphamide-induced immunosuppression; inducing apoptosis in tumor cells; and increasing MHC class I expression. The precise molecular mechanisms remain incompletely elucidated but are believed to involve both direct anti-tumor effects and potentiation of immune surveillance[1][2][3][5][6][8].

Brand names
Krestin
Other names
polysaccharide kPSKKrestinprotein-bound polysaccharide KCoriolus versicolor extractTrametes versicolor extractturkey tail glucan
02

Targets

TLR2 (Toll-like Receptor 2)

Beyond the preview

Go deeper on polysaccharide k.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polysaccharide k.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call